Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back (BOUNCE)
Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back: a Multicentre Clinical Pilot Study
Sponsor: European Institute of Oncology
A observational or N/A phase clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by European Institute of Oncology and has accumulated 5 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Jul 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jul 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Recruiting
-
Nov 2021 — Jul 2023 [monthly]
Recruiting
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Institute of Oncology
- Foundation for Research and Technology - Hellas
- Fundacao Champalimaud
- Hebrew University of Jerusalem
- Helsinki University Central Hospital
- Institute of Communications and Computer Systems, Athens, Greece
- NHG CONSULTING OY
- Noona Healthcare
- SINGULARLOGIC
For direct contact, visit the study record on ClinicalTrials.gov .